Therapeutic cancer vaccines have the potential of being integrated in the therapy of
numerous cancer types and stages. The wide spectrum of vaccine platforms and vaccine …

There are strong biologic and preclinical rationales for the development of therapeutic
cancer vaccines; however, the clinical translation of this treatment strategy has been …

Background: Cancer vaccines are a unique approach to cancer therapy. They exert an
antitumor effect by engaging the host immune response, and have great potential for …

Cancer vaccines are at the forefront of novel, targeted approaches to cancer treatment. Low
toxicity, the potential for circumventing drug cross-resistance, and the potential for …

Therapeutic cancer vaccines represent an emerging therapeutic modality that may play a
more prominent role in cancer treatment in the future. Therapeutic cancer vaccines are …

Cancer vaccines have significant theoretical therapeutic advantages over more standard
methods of cancer treatment. If a robust cellular immune response could be elicited, then …

In recent years, there has been a surge of interest in tumor microenvironment-associated
cancer vaccine therapies. These innovative treatments aim to activate and enhance the …

Cancer vaccines have been shown clinically to drive tumor-reactive cell activation,
proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer …

Therapeutic cancer vaccines are being developed with the intention of treating existing
tumors or preventing tumor recurrence. While the results of clinical trials, predominantly in …

Active, specific immunotherapy for cancer holds the potential of providing an approach for
treating cancers, which have not been controlled by conventional therapy, with very little or …